Table 1.

Overview of treatment doses and schedule for oral Olaparib, NanoOlaparib, and cisplatin

Group	Dosage	Schedule	Administration
Daily i.p. administration of NanoOlaparib
No treatment (n=5)	N/A	N/A	N/A
Vehicle (n=5)	10 µL/g bodyweight	5× weekly	i.p.
Oral Olaparib (n=5)	50 mg/kg	5× weekly	Oral gavage
NanoOlaparib (n=5)	50 mg/kg (10 µL/g bodyweight)	5× weekly	i.p.
Cisplatin (n=5)	3 mg/kg	2× weekly	i.p.
NanoOlaparib + cisplatin (n=5)	50 mg/kg (10 µL/g bodyweight) + 3 mg/kg	5× weekly + 2× weekly	i.p.
Twice weekly i.p. administration of NanoOlaparib
Vehicle (n=5)	10 µL/g bodyweight	2× weekly	i.p.
Oral Olaparib (n=5)	50 mg/kg	2× weekly	Oral gavage
NanoOlaparib (n=5)	50 mg/kg (10 µL/g bodyweight)	2× weekly	i.p.
Cisplatin (n=5)	3 mg/kg	2× weekly	i.p.
Oral Olaparib + cisplatin (n=5)	50 mg/kg + 3 mg/kg	2× weekly + 2× weekly	Oral gavage i.p.
NanoOlaparib + cisplatin (n=5)	50 mg/kg (10 µL/g bodyweight) + 3 mg/kg	2× weekly + 2× weekly	i.p.
NanoOlaparib (n=4)	100 mg/kg	2× weekly	i.p.

Abbreviation: i.p., intraperitoneal.